Literature DB >> 31912567

Divergent 2-Chloroquinazolin-4(3H)-one Rearrangement: Twisted-Cyclic Guanidine Formation or Ring-Fused N-Acylguanidines via a Domino Process.

Gang Yan1, Bereket L Zekarias1, Xiaoyu Li1, Victor A Jaffett2, Ilia A Guzei3, Jennifer E Golden1,2.   

Abstract

A highly efficient 2-chloroquinazolin-4(3H)-one rearrangement was developed that predictably generates either twisted-cyclic or ring-fused guanidines in a single operation, depending on the presence of a primary versus secondary amine in the accompanying diamine reagent. Exclusive formation of twisted-cyclic guanidines results from pairing 2-chloroquinazolinones with secondary diamines. Use of primary amine-containing diamines permits a domino quinazolinone rearrangement/intramolecular cyclization, gated through (E)-twisted-cyclic guanidines, to afford ring-fused N-acylguanidines. This scalable, structurally tolerant transformation generated 55 guanidines and delivered twisted-cyclic guanidines with robust plasma stability and an abbreviated total synthesis of an antitumor ring-fused guanidine (4 steps, 55 % yield).
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  domino; guanidine; quinazolinone; rearrangement; twisted guanidine

Mesh:

Substances:

Year:  2020        PMID: 31912567      PMCID: PMC7071832          DOI: 10.1002/chem.201905219

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  45 in total

Review 1.  The combinatorial synthesis of bicyclic privileged structures or privileged substructures.

Authors:  Douglas A Horton; Gregory T Bourne; Mark L Smythe
Journal:  Chem Rev       Date:  2003-03       Impact factor: 60.622

2.  Ti-amide catalyzed synthesis of cyclic guanidines from di-/triamines and carbodiimides.

Authors:  Hao Shen; Yang Wang; Zuowei Xie
Journal:  Org Lett       Date:  2011-08-04       Impact factor: 6.005

Review 3.  Biological activities of guanidine compounds.

Authors:  Franciszek Saczewski; Łukasz Balewski
Journal:  Expert Opin Ther Pat       Date:  2009-10       Impact factor: 6.674

Review 4.  Biological activities of guanidine compounds, 2008 - 2012 update.

Authors:  Franciszek Sączewski; Łukasz Balewski
Journal:  Expert Opin Ther Pat       Date:  2013-04-25       Impact factor: 6.674

5.  Quinazolinone analogs as potential therapeutic agents.

Authors:  P C Sharma; G Kaur; R Pahwa; A Sharma; H Rajak
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

6.  Sustainable synthesis of diverse privileged heterocycles by palladium-catalyzed aerobic oxidative isocyanide insertion.

Authors:  Tjøstil Vlaar; Razvan C Cioc; Pieter Mampuys; Bert U W Maes; Romano V A Orru; Eelco Ruijter
Journal:  Angew Chem Int Ed Engl       Date:  2012-11-14       Impact factor: 15.336

7.  α2-adrenoceptor antagonists: synthesis, pharmacological evaluation, and molecular modeling investigation of pyridinoguanidine, pyridino-2-aminoimidazoline and their derivatives.

Authors:  Brendan Kelly; Michela McMullan; Carolina Muguruza; Jorge E Ortega; J Javier Meana; Luis F Callado; Isabel Rozas
Journal:  J Med Chem       Date:  2015-01-02       Impact factor: 7.446

8.  Distal Stereocontrol Using Guanidinylated Peptides as Multifunctional Ligands: Desymmetrization of Diarylmethanes via Ullman Cross-Coupling.

Authors:  Byoungmoo Kim; Alex J Chinn; Daniel R Fandrick; Chris H Senanayake; Robert A Singer; Scott J Miller
Journal:  J Am Chem Soc       Date:  2016-06-15       Impact factor: 15.419

9.  Synthesis of cyclic guanidines via Pd-catalyzed alkene carboamination.

Authors:  Blane P Zavesky; Nicholas R Babij; Jonathan A Fritz; John P Wolfe
Journal:  Org Lett       Date:  2013-10-22       Impact factor: 6.005

10.  Guanidines as a nitrogen source for direct conversion of epoxides to aziridines.

Authors:  Yukiko Tsuchiya; Takuya Kumamoto; Tsutomu Ishikawa
Journal:  J Org Chem       Date:  2004-11-26       Impact factor: 4.354

View more
  2 in total

1.  Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones.

Authors:  Michael C Ryan; Eunjung Kim; Xufeng Cao; Walter Reichard; Tyler J Ogorek; Pronay Das; Colleen B Jonsson; Jerome Baudry; Donghoon Chung; Jennifer E Golden
Journal:  ACS Med Chem Lett       Date:  2022-03-14       Impact factor: 4.632

2.  Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity.

Authors:  Amr Sonousi; Rasha A Hassan; Eman O Osman; Amr M Abdou; Soha H Emam
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.